Patents by Inventor Simon Bjerregaard

Simon Bjerregaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20230302092
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Application
    Filed: April 4, 2023
    Publication date: September 28, 2023
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming Seier Nielsen
  • Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
    Patent number: 11622996
    Abstract: The invention relates to pharmaceutical compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: April 11, 2023
    Assignee: Novo Nordisk A/S
    Inventors: Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge
  • Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
    Publication number: 20230087952
    Abstract: The invention relates to pharmaceutical compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: November 16, 2022
    Publication date: March 23, 2023
    Inventors: Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge
  • SOLID COMPOSITIONS COMPRISING A PCSK9 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20230000949
    Abstract: The invention relates to pharmaceutical compositions comprising a PCSK9 inhibitor, such as an EGF(A) peptide, and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: November 6, 2020
    Publication date: January 5, 2023
    Inventors: Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge, Kaisa Naelapaeae
  • SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20220395559
    Abstract: The invention relates to pharmaceutical compositions comprising a GLP-1 agonist, an SLGT2 inhibitor, a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid, and a hydrotrope. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: November 6, 2020
    Publication date: December 15, 2022
    Inventors: Kaisa Naelapaeae, Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge
  • SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20220313786
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Application
    Filed: June 3, 2022
    Publication date: October 6, 2022
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming Seier Nielsen
  • Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
    Patent number: 11382957
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: July 12, 2022
    Assignee: Novo Nordisk A/S
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming Seier Nielsen
  • SOLID GLP-1 DERIVATIVE COMPOSITIONS FOR ORAL ADMINISTRATION
    Publication number: 20220016216
    Abstract: The present invention relates to solid compositions for oral administration comprising (i) a GLP-1 derivative and the SGLT2 inhibitor dapagliflozin or (ii) a GLP-1 derivative and a salt of NAC in combination with an SGLT2 inhibitor.
    Type: Application
    Filed: October 8, 2021
    Publication date: January 20, 2022
    Inventors: Andreas Vegge, Susanne Scheele, Simon Bjerregaard
  • Solid glp-1 derivative compositions for oral administration
    Patent number: 11167014
    Abstract: The present invention relates to solid compositions for oral administration comprising (i) a GLP-1 derivative and the SGLT2 inhibitor dapagliflozin or (ii) a GLP-1 derivative and a salt of NAC in combination with an SGLT2 inhibitor.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: November 9, 2021
    Assignee: Novo Nordisk A/S
    Inventors: Andreas Vegge, Susanne Scheele, Simon Bjerregaard
  • TABLET FORMULATION COMPRISING A GLP-1 PEPTIDE AND A DELIVERY AGENT
    Publication number: 20210275458
    Abstract: The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
    Type: Application
    Filed: May 14, 2021
    Publication date: September 9, 2021
    Inventors: Simon Bjerregaard, Per Sauerberg, Flemming Seier Nielsen, Betty Lomstein Pedersen, Erik Skibsted
  • Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
    Publication number: 20210236601
    Abstract: The invention relates to pharmaceutical compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: May 6, 2019
    Publication date: August 5, 2021
    Inventors: Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge
  • SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20210177944
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Application
    Filed: February 19, 2021
    Publication date: June 17, 2021
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming Seier Nielsen
  • Tablet formulation comprising a GLP-1 peptide and a delivery agent
    Patent number: 11033499
    Abstract: The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: June 15, 2021
    Assignee: Novo Nordisk A/S
    Inventors: Simon Bjerregaard Jensen, Per Sauerberg, Flemming S. Nielsen, Betty L. Pedersen, Erik Skibsted
  • Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid
    Patent number: 10960052
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: March 30, 2021
    Assignee: Novo Nordisk A/S
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming Seier Nielsen
  • SOLID COMPOSITIONS FOR ORAL ADMINISTRATION
    Publication number: 20200147179
    Abstract: The present invention relates to solid compositions for oral administration comprising (i) a GLP-1 derivative and the SGLT2 inhibitor dapagliflozin or (ii) a GLP-1 derivative and a salt of NAC in combination with an SGLT2 inhibitor.
    Type: Application
    Filed: June 11, 2018
    Publication date: May 14, 2020
    Inventors: Andreas Vegge, Susanne Scheele, Simon Bjerregaard
  • SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL) AMINO) CAPRYLIC ACID
    Publication number: 20180360918
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Application
    Filed: August 30, 2018
    Publication date: December 20, 2018
    Inventors: Per Sauerberg, Simon Bjerregaard Jensen, Flemming S. Nielsen
  • Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
    Patent number: 10086047
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: October 2, 2018
    Assignee: Novo Nordisk A/S
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming S. Nielsen
  • TABLET FORMULATION COMPRISING SEMAGLUTIDE AND A DELIVERY AGENT
    Publication number: 20180235888
    Abstract: The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
    Type: Application
    Filed: April 20, 2018
    Publication date: August 23, 2018
    Inventors: Simon Bjerregaard Jensen, Per Sauerberg, Flemming S. Nielsen, Betty L. Pedersen, Erik Skibsted
  • Tablet formulation comprising semaglutide and a delivery agent
    Patent number: 9993430
    Abstract: The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
    Type: Grant
    Filed: June 19, 2013
    Date of Patent: June 12, 2018
    Assignee: Novo Nordisk A/S
    Inventors: Simon Bjerregaard Jensen, Per Sauerberg, Flemming S. Nielsen, Betty L. Pedersen, Erik Skibsted
  • Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
    Patent number: 9387176
    Abstract: The present invention relates to a method for spray-drying of protein solutions and the spray-dried protein product. The invention also relates to pharmaceutical compositions containing such spray-dried protein, to methods of treating diabetes and hyperglycaemia using the spray-dried protein of the invention and to the use of such spray-dried protein in the treatment of diabetes and hyperglycaemia.
    Type: Grant
    Filed: April 30, 2008
    Date of Patent: July 12, 2016
    Assignee: Novo Nordisk A/S
    Inventors: Svend Havelund, Simon Bjerregaard Jensen